Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0GR2J
|
|||
Former ID |
DIB003429
|
|||
Drug Name |
Idoxifene
|
|||
Synonyms |
CB-7432; SB-223030
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Breast cancer [ICD-11: 2C60-2C65] | Discontinued in Phase 3 | [1] | |
Company |
Institute of Cancer Research UK
|
|||
Structure |
Download2D MOL |
|||
Formula |
C28H30INO
|
|||
Canonical SMILES |
CCC(=C(C1=CC=C(C=C1)OCCN2CCCC2)C3=CC=C(C=C3)I)C4=CC=CC=C4
|
|||
InChI |
1S/C28H30INO/c1-2-27(22-8-4-3-5-9-22)28(23-10-14-25(29)15-11-23)24-12-16-26(17-13-24)31-21-20-30-18-6-7-19-30/h3-5,8-17H,2,6-7,18-21H2,1H3/b28-27-
|
|||
InChIKey |
JJKOTMDDZAJTGQ-DQSJHHFOSA-N
|
|||
CAS Number |
CAS 116057-75-1
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003448) | |||
REF 2 | Idoxifene: a novel selective estrogen receptor modulator prevents bone loss and lowers cholesterol levels in ovariectomized rats and decreases uterine weight in intact rats. Endocrinology. 1998 Dec;139(12):5224-34. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.